These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8768856)

  • 1. Effect of MK-386, a novel inhibitor of type 1 5 alpha-reductase, alone and in combination with finasteride, on serum dihydrotestosterone concentrations in men.
    Schwartz JI; Van Hecken A; De Schepper PJ; De Lepeleire I; Lasseter KC; Shamblen EC; Winchell GA; Constanzer ML; Chavez CM; Wang DZ; Ebel DL; Justice SJ; Gertz BJ
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2942-7. PubMed ID: 8768856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MK-386, an inhibitor of 5alpha-reductase type 1, reduces dihydrotestosterone concentrations in serum and sebum without affecting dihydrotestosterone concentrations in semen.
    Schwartz JI; Tanaka WK; Wang DZ; Ebel DL; Geissler LA; Dallob A; Hafkin B; Gertz BJ
    J Clin Endocrinol Metab; 1997 May; 82(5):1373-7. PubMed ID: 9141518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of finasteride (MK-906), a 5 alpha-reductase inhibitor, on circulating androgens in male volunteers.
    Gormley GJ; Stoner E; Rittmaster RS; Gregg H; Thompson DL; Lasseter KC; Vlasses PH; Stein EA
    J Clin Endocrinol Metab; 1990 Apr; 70(4):1136-41. PubMed ID: 2156887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of finasteride, a 5 alpha-reductase inhibitor, on serum gonadotropins in normal men.
    Rittmaster RS; Lemay A; Zwicker H; Capizzi TP; Winch S; Moore E; Gormley GJ
    J Clin Endocrinol Metab; 1992 Aug; 75(2):484-8. PubMed ID: 1322427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A model for the turnover of dihydrotestosterone in the presence of the irreversible 5 alpha-reductase inhibitors GI198745 and finasteride.
    Gisleskog PO; Hermann D; Hammarlund-Udenaes M; Karlsson MO
    Clin Pharmacol Ther; 1998 Dec; 64(6):636-47. PubMed ID: 9871428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. III. Higher 5 alpha-reductase activity in oligozoospermic men administered supraphysiological doses of testosterone.
    Anderson RA; Wallace AM; Wu FC
    J Clin Endocrinol Metab; 1996 Mar; 81(3):902-8. PubMed ID: 8772548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of MK-906, a specific 5 alpha-reductase inhibitor, on serum androgens and androgen conjugates in normal men.
    Rittmaster RS; Stoner E; Thompson DL; Nance D; Lasseter KC
    J Androl; 1989; 10(4):259-62. PubMed ID: 2550402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of finasteride, a 5 alpha-reductase inhibitor, on scalp skin testosterone and dihydrotestosterone concentrations in patients with male pattern baldness.
    Dallob AL; Sadick NS; Unger W; Lipert S; Geissler LA; Gregoire SL; Nguyen HH; Moore EC; Tanaka WK
    J Clin Endocrinol Metab; 1994 Sep; 79(3):703-6. PubMed ID: 8077349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hair growth effects of oral administration of finasteride, a steroid 5 alpha-reductase inhibitor, alone and in combination with topical minoxidil in the balding stumptail macaque.
    Diani AR; Mulholland MJ; Shull KL; Kubicek MF; Johnson GA; Schostarez HJ; Brunden MN; Buhl AE
    J Clin Endocrinol Metab; 1992 Feb; 74(2):345-50. PubMed ID: 1309834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of 5alpha-reductase inhibition with dutasteride and finasteride on semen parameters and serum hormones in healthy men.
    Amory JK; Wang C; Swerdloff RS; Anawalt BD; Matsumoto AM; Bremner WJ; Walker SE; Haberer LJ; Clark RV
    J Clin Endocrinol Metab; 2007 May; 92(5):1659-65. PubMed ID: 17299062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unique preclinical characteristics of GG745, a potent dual inhibitor of 5AR.
    Bramson HN; Hermann D; Batchelor KW; Lee FW; James MK; Frye SV
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1496-502. PubMed ID: 9316864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The androgen control of sebum production. Studies of subjects with dihydrotestosterone deficiency and complete androgen insensitivity.
    Imperato-McGinley J; Gautier T; Cai LQ; Yee B; Epstein J; Pochi P
    J Clin Endocrinol Metab; 1993 Feb; 76(2):524-8. PubMed ID: 8381804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of 5 alpha-reductase inhibitors on intraprostatic androgens in the rat.
    di Salle E; Giudici D; Biagini L; Cominato C; Briatico G; Panzeri A
    J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):381-5. PubMed ID: 7626485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormonal effects, tolerability, and preliminary kinetics in men of MK-906, a 5 alpha-reductase inhibitor.
    De Schepper PJ; Imperato-McGinley J; Van Hecken A; De Lepeleire I; Buntinx A; Carlin J; Gressi MH; Stoner E
    Steroids; 1991 Sep; 56(9):469-71. PubMed ID: 1666698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of dutasteride on reduction of plasma DHT following finasteride therapy in patients with benign prostatic hyperplasia].
    Botto H; Lan O; Poulain JE; Comenducci A
    Prog Urol; 2005 Dec; 15(6):1090-5. PubMed ID: 16429658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen metabolism in the prostate of the finasteride-treated, adult rat: a possible explanation for the differential action of testosterone and 5 alpha-dihydrotestosterone during development of the male urogenital tract.
    George FW
    Endocrinology; 1997 Mar; 138(3):871-7. PubMed ID: 9048585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of finasteride, a 5 alpha-reductase inhibitor on prostate tissue androgens and prostate-specific antigen.
    Geller J
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1552-5. PubMed ID: 1699965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormonal effects of an orally active 4-azasteroid inhibitor of 5 alpha-reductase in humans.
    Vermeulen A; Giagulli VA; De Schepper P; Buntinx A; Stoner E
    Prostate; 1989; 14(1):45-53. PubMed ID: 2538808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen-induced regrowth in the castrated rat ventral prostate: role of 5alpha-reductase.
    Wright AS; Douglas RC; Thomas LN; Lazier CB; Rittmaster RS
    Endocrinology; 1999 Oct; 140(10):4509-15. PubMed ID: 10499505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of 5-alpha-reductase inhibition on sex-hormone-binding globulin in elderly men.
    Jaffe A; Matzkin H; Gilad S; Stern N
    Horm Res; 1994; 41(5-6):215-7. PubMed ID: 7525442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.